← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA635.4x10.5x17.9x
EV / LTM revenue720.6x1.6x3.1x
Premium to unaffected price8816%26%37%
Premium to 30-day VWAP1113%15%35%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
01142282009: 17 deals, 2 clean on every measure2009172010: 226 deals, 40 clean on every measure20102262011: 208 deals, 92 clean on every measure20112082012: 185 deals, 117 clean on every measure20121852013: 198 deals, 136 clean on every measure20131982014: 180 deals, 85 clean on every measure20141802015: 196 deals, 108 clean on every measure20151962016: 228 deals, 142 clean on every measure20162282017: 187 deals, 109 clean on every measure20171872018: 208 deals, 113 clean on every measure20182082019: 195 deals, 108 clean on every measure20191952020: 142 deals, 73 clean on every measure20201422021: 194 deals, 99 clean on every measure20211942022: 161 deals, 98 clean on every measure20221612023: 156 deals, 86 clean on every measure20231562024: 174 deals, 109 clean on every measure20241742025: 186 deals, 98 clean on every measure20251862026: 97 deals, 54 clean on every measure202697
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Healthcare: 17.4x median across 5 dealsHealthcare17.4xn=5Technology: 17.1x median across 9 dealsTechnology17.1xn=9Real Estate: 16.2x median across 5 dealsReal Estate16.2xn=5Industrials: 14.8x median across 14 dealsIndustrials14.8xn=14Business Services: 10.4x median across 4 dealsBusiness Services10.4xn=4Utilities: 8.7x median across 4 dealsUtilities8.7xn=4Consumer & Retail: 8.6x median across 13 dealsConsumer & Retail8.6xn=13Other: 5.4x median across 4 dealsOther5.4xn=4
Deals by sector
Financials: 36 dealsFinancials36Healthcare: 26 dealsHealthcare26Industrials: 22 dealsIndustrials22Consumer & Retail: 20 dealsConsumer & Retail20Technology: 17 dealsTechnology17Utilities: 12 dealsUtilities12Real Estate: 11 dealsReal Estate11Business Services: 10 dealsBusiness Services10Other: 9 dealsOther9Energy: 8 dealsEnergy8Media & Telecom: 7 dealsMedia & Telecom7Materials: 2 dealsMaterials2
Deals by buyer type
Financial sponsor: 5 dealsFinancial sponsor5Strategic: 114 dealsStrategic114Management / founder: 0 dealsManagement / founder0Controlling holder: 0 dealsControlling holder0Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 61 dealsUnclassified61
Deals by enterprise value
Under $250m: 79 dealsUnder $250m79$250m to $1bn: 26 deals$250m to $1bn26$1bn to $5bn: 44 deals$1bn to $5bn44$5bn to $20bn: 20 deals$5bn to $20bn20Over $20bn: 10 dealsOver $20bn10Not computed: 1 dealsNot computed1
Deals by industry code
Depository Institutions: 29 dealsDepository Institutions29Business Services & Software: 18 dealsBusiness Services & Sof…18Chemicals, Pharmaceuticals & Allied Products: 16 dealsChemicals, Pharmaceutic…16Electric, Gas & Sanitary Services: 12 dealsElectric, Gas & Sanitar…12Instruments, Medical Devices & Optical Goods: 10 dealsInstruments, Medical De…10Holding & Other Investment Offices: 10 dealsHolding & Other Investm…10Industrial Machinery & Computers: 9 dealsIndustrial Machinery & …9Electronics & Electrical Equipment: 7 dealsElectronics & Electrica…7Oil & Gas Extraction: 6 dealsOil & Gas Extraction6Communications: 6 dealsCommunications6
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
Ameritrust Group, Inc.
2014-12-30 · Public merger · $8.65 a share
Miracle Nova II, LLC
Strategic
Financials$408mn.a.0.5x
24%
DEFM14A
All cash
Uroplasty Inc
2014-12-21 · Public merger · $0.78 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Vision-Sciences, Inc.
Strategic
Healthcare$8mn.a.0.3x
56%
DEFM14A
Includes stock
Pantry Inc
2014-12-18 · Public merger · $36.75 a share
Couche-Tard U.S. Inc.
Strategic
Consumer & Retail$1.3bn5.9x0.2x
3%
DEFM14A
All cash
Vaporin, Inc.
2014-12-17 · Public merger · $0.10 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Not named in the filing
Unclassified
Consumer & Retail-$0mn.a.n.a.
n.a.
DEFM14A
Includes stock
Cover All Technologies Inc
2014-12-14 · Public merger · $0.82 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Not named in the filing
Unclassified
Technology$21mn.a.1.1x
n.a.
DEFM14A
Includes stock
Petsmart Inc
2014-12-14 · Public merger · $83.00 a share
Argos Holdings Inc.
Strategic
Consumer & Retail$8.1bn8.6x1.1x
n.a.
DEFM14A
All cash
Riverbed Technology, Inc.
2014-12-14 · Public merger · $21.00 a share
Project Homestake Holdings, LLC
Strategic
Industrials$3.4bn18.3x3.1x
12%
DEFM14A
All cash
Heritage Financial Group Inc
2014-12-10 · Public merger · $27.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; no balance sheet at announcement: EV = equity value
Renasant Bank
Strategic
Financials$248mn.a.n.a.
27%
DEFM14A
Includes stock
Alico, Inc.
2014-12-02 · Public merger · $36.85 a share
734 Sub, LLC
Strategic
Other$274m17.5x3.1x
n.a.
DEFM14C
All cash
Spansion Inc.
2014-12-01 · Public merger · $27.30 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Cypress Semiconductor Corporation
Strategic
Technology$1.8bn22.4x1.4x
n.a.
DEFM14A
Includes stock
Platinum Underwriters Holdings Ltd
2014-11-23 · Public merger · $35.96 a share
Held out of the multiples: EV / LTM EBITDA 5008.0x outside 1x to 75x; EV / LTM revenue 1474.9x above 60x
Renaissancere Holdings LTD.
Strategic
Financials$891bn5008.0x1474.9x
24%
DEFM14A
All cash
Signature Office REIT Inc
2014-11-21 · Public merger · $21.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Not named in the filing
Unclassified
Real Estate$424m14.7x5.7x
n.a.
DEFM14A
Includes stock
Covidien plc
2014-11-21 (filed) · Public merger · $35.19 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Not named in the filing
Unclassified
Healthcare$19bn7.5xn.a.
n.a.
DEFM14A
Includes stock
Medtronic Inc
2014-11-21 (filed) · Public merger · $35.19 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Not named in the filing
Unclassified
Healthcare$34bnn.a.1.9x
n.a.
DEFM14A
Includes stock
MidWestOne Financial Group, Inc.
2014-11-20 · Public merger · $1.00 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Not named in the filing
Unclassified
Financials$8mn.a.n.a.
n.a.
DEFM14A
All cash
ChyronHego Corp
2014-11-17 · Public merger · $2.82 a share
Vector CH Holdings, L.P.
Strategic
Business Services$110mn.a.1.9x
4%
DEFM14A
All cash
ChyronHego Corp
2014-11-17 · Take-private · $2.82 a share
Vector CH Holdings, L.P.
Strategic
Business Services$110mn.a.1.9x
4%
SC 13E3
All cash
Auxilium Pharmaceuticals Inc
2014-11-17 · Public merger · $33.25 a share
QLT Holding Corp.
Strategic
Healthcare$1.9bnn.a.n.a.
n.a.
DEFM14A
All cash
Valley Financial Corp /Va/
2014-11-17 · Public merger · $20.50 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
BNC Bancorp
Strategic
Financials$85mn.a.n.a.
n.a.
DEFM14A
Includes stock
Cadista Holdings Inc.
2014-11-17 (filed) · Take-private · $1.60 a share
Not named in the filing
Unclassified
Healthcare$173mn.a.1.6x
n.a.
SC 13E3
All cash
Baker Hughes Holdings LLC
2014-11-16 · Public merger · $19.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Red Tiger LLC
Strategic
Industrials$11bn2.8x0.5x
54%
DEFM14A
Includes stock
Allergan Inc
2014-11-16 · Public merger · $129.22 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Actavis plc
Strategic
Healthcare$36bn17.1x5.1x
19%
DEFM14A
Includes stock
Cadista Holdings Inc.
2014-11-13 (filed) · Take-private · $1.60 a share
Not named in the filing
Unclassified
Healthcare$173mn.a.1.6x
n.a.
SC 13E3
All cash
Horizon Lines, Inc.
2014-11-11 · Public merger · $0.72 a share
Matson Navigation Company, Inc.
Strategic
Industrials$562m8.1xn.a.
90%
DEFM14A
All cash
Susquehanna Bancshares Inc
2014-11-11 · Public merger · $4.05 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
BB&T Corporation
Strategic
Financials-$79mn.a.n.a.
n.a.
DEFM14A
Includes stock

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More